← SynDRA
TRIFAROTENE
SynDRA canonical compound SYN0038476 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | RARA | RARB | RARG |
|---|
| Mechanism of action | retinoid receptor agonist |
|---|
| Indication | acne vulgaris (av) |
|---|
| Disease area | dermatology |
|---|
All known targets
Mechanisms of action (all sources)
- RARG AGONIST
- Retinoic acid receptor gamma agonist
- RARA AGONIST
- RARB AGONIST
- retinoid receptor agonist
Drug classes
- Dermatologic Agents
- Retinoid
ATC classes
- D10A · ANTI-ACNE PREPARATIONS FOR TOPICAL USE
Cross-references
Synonyms
- AKLIEF
- Aklief
- CD5789
- aklief
- Trifaroteno
- CD-5789
- UNII-0J8RN2W0HK
- 0J8RN2W0HK
- Trifarotene [USAN:INN]
- CD 5789
- SCHEMBL381493
- GTPL9962
- CHEMBL3707313
- DTXSID30237781
- EX-A2704
- DB12808
- compound 15b [PMID: 29706423]
- HY-100256
- CS-0018407
- trifaroteno
- trifarotenum
- RefChem:56760
- D10AD06
- DTXCID80160272
- Trifarotene [INN]
- Aklief (TN)
- Trifarotene (Standard)
- TRIFAROTENE [MI]
- Trifarotene (USAN/INN)
- TRIFAROTENE [USAN]
- TRIFAROTENE [WHO-DD]
- orb1299684
- TRIFAROTENE [ORANGE BOOK]
- BDBM50457548
- EBC-27154
- AKOS037649283
- AT10456
- HY-100256R
Reported adverse events
- Application site irritation
- Application site pruritus
- Erythema
- Skin irritation
- Sunburn
Look up TRIFAROTENE in the interactive SynDRA portal →